Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

Activist hedge fund Parvus Asset Management is building a stake in Ozempic-maker Novo Nordisk as the drugmaker hunts for a ...

Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk, after the company lost its first mover ...

This update covers current health news, focusing on Parvus Asset Management's influence on Novo Nordisk's CEO selection, ...

The current health news highlights a series of dynamic events, including Parvus Asset Management's stake in Novo Nordisk, WHO ...

Investing.com -- Parvus Asset Management, a London-based activist hedge fund, is acquiring a stake in Danish pharmaceutical company Novo Nordisk (NYSE: NVO ), according to The Financial Times. The ...

Moelis threw himself into action, developing a reputation as one of the best connected bankers on Wall Street. In 2014, Moelis & Company went public and it now has a market capitalisation of more than ...

Ryanair Holdings ( ($RYAAY) ) has issued an announcement. On June 2, 2025, Ryanair Holdings Plc was notified of a significant change in the ...

Parvus Asset Management Europe Limited has notified control of the voting rights of 4,981,743 shares in the Company equivalent to 4.9817% of the total share capital and voting rights.

MILAN, May 16 (Reuters) - London-based fund Parvus Asset Management has increased its holding in UniCredit (CRDI.MI), opens new tab to 5%, becoming the second-biggest investor in the Italian bank ...

PARIS, April 3 (Reuters) - UK hedge fund Parvus Asset Management has taken a 16.6 percent stake in French ad group Havas, according to a filing with France's AMF financial regulator published on ...